Explore the diversity and abundance of business activity in Ireland as it happens. You can filter the content to see what is happening in a particular sector/area. After filtering the content, you can erase specific criteria simply by using your mouse to click on the ‘x’ beside each one you want to delete.
Facilitates production of an oncology treatment for global markets puts Drug Substance, Drug Product, Packaging, Innovation and Quality Control all under one roof.
Today, Minister for Business, Enterprise and Innovation, Heather Humphreys T.D., visited Pfizer Ringaskiddy almost 50 years to the day the company first came to Ireland. During her visit, the Minister recognised the significance of this anniversary and the substantial investment of Pfizer in Ireland over the last five decades. The Minister toured part of the large-scale manufacturing site, visiting the New Product Technology Lab, a state of the art $30 Million facility. The visit is part of a series of events to celebrate the company’s 50th anniversary in Ireland.
Global life-science innovation leader, Allergan, which is headquartered in Ireland and operates four facilities here, has announced a €65 million capital investment programme for 2019 to facilitate the continued expansion of the company’s state-of-the art laboratories and manufacturing campuses at Westport in County Mayo and Clonshaugh in north Dublin. The Westport facility has created 63 new highly skilled jobs, bringing total employment in Ireland to more than 2,000 across the country. One in ten employees in Allergan’s global workforce is based in Ireland.
Greenfield Global Inc., Canada’s largest producer of alcohol and fuel ethanol, and one of the largest alcohols and solvents companies in North America, today announced plans to establish a new EU manufacturing headquarters in Portlaoise, Ireland.
Creation of 100 new jobs by global human data sciences innovator
Zimmer Biomet, is celebrating a decade in Ireland. A leading employer in Shannon and Oranmore, Galway, the company’s footprint in Ireland now features two state-of-the-art manufacturing facilities plus a professional education centre that attracts healthcare professionals from around the world.
Move to new, larger premises in Waterford signals company’s plans to develop a flagship facility to spearhead its activities in Ireland and worldwide
Agilent Technologies Ireland Ltd. today held the official opening of a new, purpose-built research and development extension to its Little Island, County Cork facility.
Shire held an official site dedication event at its new state of-the-art biologics facility in Dunboyne, Co. Meath today.
Development of the 120-acre site has been underway since November 2017. Approximately 400 people will be employed at the facility when it is at full capacity.
ILC Dover, a global leader in flexible containment solutions for the pharmaceutical and biopharmaceutical industry today announced it is expanding its Irish production footprint by opening a location in Blarney, County Cork, Ireland creating up to 70 jobs over two years.
Biotechnology company Regeneron had two reasons to be cheerful after the inaugural Invest in Ireland Awards in October. The company came away with the Grand Prix and also won the ‘Excellence in Regional Investment’ category. The recognition follows five years of expansion in Ireland since the company first announced its presence here in 2013.
The 29th of March next year is a critical date for U.S. biotech companies because business as usual disappears in Europe as a result of Brexit. Long a favored location for manufacturing and selling pharmaceuticals and devices across Europe, the United Kingdom will no longer be part of the EU and so free trade across Europe will change. American firms with UK operations should have already devised a post-Brexit strategy and begun implementing it given the fact that the changeover is just a few months away.
An Taoiseach Leo Varadkar TD, Minister for Business, Enterprise and Innovation Heather Humphreys TD and IDA Ireland today welcomed the announcement that MSD is to construct a second manufacturing facility at its existing site in Carlow with the creation of 170 new jobs.
Edwards Lifesciences Corporation, the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced National Technology Park, Castletroy, Limerick, as the location of its new permanent facility which is expected to manufacture delivery components for its transcatheter heart valve therapies.
BioMarin International Ltd. is investing in a new Drug Product Filling Project at its Shanbally, Co. Cork facility. This project will allow the company to maximise the flexibility of the site with the expansion of the operational manufacturing capacity to meet the rise in the global demand for its therapies to treat rare genetic diseases that mostly affect children.
IDA Ireland welcomes today’s statement from Abbott in Donegal that it is to expand its existing manufacturing facility which will result in the creation of c.500 new jobs over the next number of years.
The newest drugs emerging in the market for gene and cell therapy as well as disposables have become the focus area for U.S. bioprocessing firms, many of whom have been moving some production overseas -- particularly to Europe. But while single-use products have advantages in production costs and turnaround time, there are also some challenges for American biopharma companies in choosing their optimal overseas location.
You'll find us responsive to your needs, proactive, professional and willing to go the extra mile.
We have 28 Offices worldwide helping support companies expand their operations in Ireland.